How have ENZN shares performed in 2024?

Enzon Pharmaceuticals' stock was trading at $0.0936 at the beginning of the year. Since then, ENZN shares have decreased by 22.7% and is now trading at $0.0724. View the best growth stocks for 2024 here .

Are investors shorting Enzon Pharmaceuticals?

Enzon Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,800 shares, an increase of 137.5% from the March 15th total of 1,600 shares. Based on an average trading volume of 50,100 shares, the short-interest ratio is presently 0.1 days. View Enzon Pharmaceuticals' Short Interest .

How were Enzon Pharmaceuticals' earnings last quarter?

Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) released its earnings results on Wednesday, March, 20th. The biotechnology company reported $0.01 earnings per share for the quarter.

What other stocks do shareholders of Enzon Pharmaceuticals own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Enzon Pharmaceuticals investors own include Aeterna Zentaris (AEZS) , CBL & Associates Properties (CBL) , Pennsylvania Real Estate Investment Trust (PEI) , CNBX Pharmaceuticals (CNBX) , Gran Tierra Energy (GTE) , Golar LNG Partners (GMLP) , Washington Prime Group (WPG) , DHT (DHT) , Hallador Energy (HNRG) and Medical Marijuana (MJNA) .

How do I buy shares of Enzon Pharmaceuticals?

Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

OTCMKTS:ENZN

Enzon Pharmaceuticals (ENZN) Stock Price, News & Analysis

→ Tiny Biotech Stock Wins $75 Billion Patent (From Behind the Markets) (Ad)

Free ENZN Stock Alerts

$0.07

0.00 (0.00%)

(As of 04/18/2024 ET)

Compare

Today's Range: $0.07
▼
$0.07
50-Day Range: $0.06
▼
$0.09
52-Week Range: $0.06
▼
$0.23

Volume: N/A
Average Volume: 12,737 shs
Market Capitalization: N/A

P/E Ratio: 7.24
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Chart Earnings Financials SEC Filings Short Interest

Get Enzon Pharmaceuticals alerts:

Ad Altimetry

Secret Bull Market Starts in This Unusual Sector

"We're only at the very beginning of a new wave that could deliver 500%-plus gains in the years to come." In fact, 50 small companies related to this sector have already soared 100% or more in a recent 90-day stretch.

Click for my No. 1 investment, all free of charge, click here.

About Enzon Pharmaceuticals Stock (OTCMKTS:ENZN)

Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company's marketed drug product is PegIntron. It also has a marketing agreement relating to Vicineum drug. The company was founded in 1981 and is headquartered in Cranford, New Jersey.

ENZN Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ENZN Stock News Headlines

November 8, 2023 | morningstar.com

Enzon Pharmaceuticals Inc ENZN

October 25, 2023 | finance.yahoo.com

OKYO Pharma Limited (OK10.F)

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.

July 30, 2023 | nasdaq.com

Regeneron Pharmaceuticals, Inc. Common Stock (REGN)

March 26, 2023 | thestreet.com

Enzon Stock Hits New 52-Week Low (ENZN)

March 20, 2023 | investing.com

Ibnsina Pharma Co (ISPH)

February 26, 2023 | time.com

Big Pharma’s Patent Abuses Are Fueling the Drug Pricing Crisis

July 15, 2022 | morningstar.com

Enzon Pharmaceuticals Inc - Stock Operating Performance ENZN

April 19, 2024 | Behind the Markets (Ad)

Tiny Biotech Stock Wins $75 Billion Patent

July 2, 2022 | finance.yahoo.com

Enzon Pharmaceuticals, Inc. (ENZN)

See More Headlines

Receive ENZN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Enzon Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 3/20/2024
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Sector: Medical
Industry: Biological products, except diagnostic
Sub-Industry: Biotechnology
Current Symbol: OTCMKTS:ENZN
Previous Symbol: NASDAQ:ENZN
CUSIP: 29390410
CIK: 727510
Web: www.enzon.com
Phone: (732) 980-4500
Fax: 732-980-4585
Employees: N/A
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.01
Trailing P/E Ratio: 7.24
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $1.37 million
Net Margins: N/A
Pretax Margin: 3,573.08%
Return on Equity: 46.47%
Return on Assets: 2.92%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 27.62
Quick Ratio: 27.62

Sales & Book Value

Annual Sales: $30,000.00
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: N/A
Price / Book: N/A

Miscellaneous

Outstanding Shares: N/A
Free Float: N/A
Market Cap: N/A
Optionable: Not Optionable
Beta: 0.33

13 Stocks Institutional Investors Won't Stop Buying

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

Mr. Richard L. Feinstein (Age 81)
CEO, CFO & Company Secretary
Comp: $209.45k

Key Competitors

View All Competitors

ENZN Stock Analysis - Frequently Asked Questions

How have ENZN shares performed in 2024?: Enzon Pharmaceuticals' stock was trading at $0.0936 at the beginning of the year. Since then, ENZN shares have decreased by 22.7% and is now trading at $0.0724.
View the best growth stocks for 2024 here.
Are investors shorting Enzon Pharmaceuticals?: Enzon Pharmaceuticals saw a increase in short interest in March. As of March 31st, there was short interest totaling 3,800 shares, an increase of 137.5% from the March 15th total of 1,600 shares. Based on an average trading volume of 50,100 shares, the short-interest ratio is presently 0.1 days.
View Enzon Pharmaceuticals' Short Interest.
How were Enzon Pharmaceuticals' earnings last quarter?: Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) released its earnings results on Wednesday, March, 20th. The biotechnology company reported $0.01 earnings per share for the quarter.

What other stocks do shareholders of Enzon Pharmaceuticals own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Enzon Pharmaceuticals investors own include Aeterna Zentaris (AEZS), CBL & Associates Properties (CBL), Pennsylvania Real Estate Investment Trust (PEI), CNBX Pharmaceuticals (CNBX), Gran Tierra Energy (GTE), Golar LNG Partners (GMLP), Washington Prime Group (WPG), DHT (DHT), Hallador Energy (HNRG) and Medical Marijuana (MJNA).
How do I buy shares of Enzon Pharmaceuticals?: Shares of ENZN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:ENZN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial